Passage Bio earnings were -$63.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PASG earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$15.4M, up 21.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PASG reported annual earnings of -$64.8M, with -36.5% growth.
On PASG's earnings call on Invalid Date, Passage Bio (NASDAQ: PASG) reported Q1 2025 earnings per share (EPS) of -$0.25, up 16.67% year over year. Total PASG earnings for the quarter were -$15.41 million. In the same quarter last year, Passage Bio's earnings per share (EPS) was -$0.30.
As of the last Passage Bio earnings report, Passage Bio is currently losing money. Passage Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$63.46 million, a 24.84% decrease year over year.
What was PASG's earnings growth in the past year?
As of Passage Bio's earnings date in Invalid Date, Passage Bio's earnings has grown year over year. PASG earnings in the past year totalled -$63.46 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.